Global Biopharmaceutical Logistic Market Analysis and Forecast 2024-2030

Global Biopharmaceutical Logistic Market Analysis and Forecast 2024-2030


Summary

Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.

According to APO Research, The global Biopharmaceutical Logistic market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biopharmaceutical Logistic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Biopharmaceutical Logistic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Biopharmaceutical Logistic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Biopharmaceutical Logistic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Biopharmaceutical Logistic include Deutsche Post DHL, Kuehne + Nagel, FedEx, AmerisourceBergen, UPS (Marken), DB Schenker, XPO Logistics, Panalpina and Nippon Express, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for Biopharmaceutical Logistic, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Biopharmaceutical Logistic, also provides the revenue of main regions and countries. Of the upcoming market potential for Biopharmaceutical Logistic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biopharmaceutical Logistic revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Biopharmaceutical Logistic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biopharmaceutical Logistic revenue, projected growth trends, production technology, application and end-user industry.

Biopharmaceutical Logistic segment by Company

Deutsche Post DHL
Kuehne + Nagel
FedEx
AmerisourceBergen
UPS (Marken)
DB Schenker
XPO Logistics
Panalpina
Nippon Express
GEODIS
VersaCold
Agility
DSV
Sinotrans
Kerry Logistics
SF Express
CEVA
CH Robinson
Air Canada Cargo
Biopharmaceutical Logistic segment by Type

Cold Chain Logistics
Non-cold Chain Logistics
Biopharmaceutical Logistic segment by Application

Ground Shipping
Sea Shipping
Air Shipping
Biopharmaceutical Logistic segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Logistic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Logistic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Logistic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Biopharmaceutical Logistic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Biopharmaceutical Logistic company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceutical Logistic revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Biopharmaceutical Logistic Market by Type
1.2.1 Global Biopharmaceutical Logistic Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Cold Chain Logistics
1.2.3 Non-cold Chain Logistics
1.3 Biopharmaceutical Logistic Market by Application
1.3.1 Global Biopharmaceutical Logistic Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Ground Shipping
1.3.3 Sea Shipping
1.3.4 Air Shipping
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Biopharmaceutical Logistic Market Dynamics
2.1 Biopharmaceutical Logistic Industry Trends
2.2 Biopharmaceutical Logistic Industry Drivers
2.3 Biopharmaceutical Logistic Industry Opportunities and Challenges
2.4 Biopharmaceutical Logistic Industry Restraints
3 Global Growth Perspective
3.1 Global Biopharmaceutical Logistic Market Perspective (2019-2030)
3.2 Global Biopharmaceutical Logistic Growth Trends by Region
3.2.1 Global Biopharmaceutical Logistic Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Biopharmaceutical Logistic Market Size by Region (2019-2024)
3.2.3 Global Biopharmaceutical Logistic Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Biopharmaceutical Logistic Revenue by Players
4.1.1 Global Biopharmaceutical Logistic Revenue by Players (2019-2024)
4.1.2 Global Biopharmaceutical Logistic Revenue Market Share by Players (2019-2024)
4.1.3 Global Biopharmaceutical Logistic Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Biopharmaceutical Logistic Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Biopharmaceutical Logistic Key Players Headquarters & Area Served
4.4 Global Biopharmaceutical Logistic Players, Product Type & Application
4.5 Global Biopharmaceutical Logistic Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Biopharmaceutical Logistic Market CR5 and HHI
4.6.2 Global Top 5 and 10 Biopharmaceutical Logistic Players Market Share by Revenue in 2023
4.6.3 2023 Biopharmaceutical Logistic Tier 1, Tier 2, and Tier 3
5 Biopharmaceutical Logistic Market Size by Type
5.1 Global Biopharmaceutical Logistic Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Biopharmaceutical Logistic Revenue by Type (2019-2030)
5.3 Global Biopharmaceutical Logistic Revenue Market Share by Type (2019-2030)
6 Biopharmaceutical Logistic Market Size by Application
6.1 Global Biopharmaceutical Logistic Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Biopharmaceutical Logistic Revenue by Application (2019-2030)
6.3 Global Biopharmaceutical Logistic Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Deutsche Post DHL
7.1.1 Deutsche Post DHL Comapny Information
7.1.2 Deutsche Post DHL Business Overview
7.1.3 Deutsche Post DHL Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.1.4 Deutsche Post DHL Biopharmaceutical Logistic Product Portfolio
7.1.5 Deutsche Post DHL Recent Developments
7.2 Kuehne + Nagel
7.2.1 Kuehne + Nagel Comapny Information
7.2.2 Kuehne + Nagel Business Overview
7.2.3 Kuehne + Nagel Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.2.4 Kuehne + Nagel Biopharmaceutical Logistic Product Portfolio
7.2.5 Kuehne + Nagel Recent Developments
7.3 FedEx
7.3.1 FedEx Comapny Information
7.3.2 FedEx Business Overview
7.3.3 FedEx Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.3.4 FedEx Biopharmaceutical Logistic Product Portfolio
7.3.5 FedEx Recent Developments
7.4 AmerisourceBergen
7.4.1 AmerisourceBergen Comapny Information
7.4.2 AmerisourceBergen Business Overview
7.4.3 AmerisourceBergen Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.4.4 AmerisourceBergen Biopharmaceutical Logistic Product Portfolio
7.4.5 AmerisourceBergen Recent Developments
7.5 UPS (Marken)
7.5.1 UPS (Marken) Comapny Information
7.5.2 UPS (Marken) Business Overview
7.5.3 UPS (Marken) Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.5.4 UPS (Marken) Biopharmaceutical Logistic Product Portfolio
7.5.5 UPS (Marken) Recent Developments
7.6 DB Schenker
7.6.1 DB Schenker Comapny Information
7.6.2 DB Schenker Business Overview
7.6.3 DB Schenker Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.6.4 DB Schenker Biopharmaceutical Logistic Product Portfolio
7.6.5 DB Schenker Recent Developments
7.7 XPO Logistics
7.7.1 XPO Logistics Comapny Information
7.7.2 XPO Logistics Business Overview
7.7.3 XPO Logistics Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.7.4 XPO Logistics Biopharmaceutical Logistic Product Portfolio
7.7.5 XPO Logistics Recent Developments
7.8 Panalpina
7.8.1 Panalpina Comapny Information
7.8.2 Panalpina Business Overview
7.8.3 Panalpina Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.8.4 Panalpina Biopharmaceutical Logistic Product Portfolio
7.8.5 Panalpina Recent Developments
7.9 Nippon Express
7.9.1 Nippon Express Comapny Information
7.9.2 Nippon Express Business Overview
7.9.3 Nippon Express Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.9.4 Nippon Express Biopharmaceutical Logistic Product Portfolio
7.9.5 Nippon Express Recent Developments
7.10 GEODIS
7.10.1 GEODIS Comapny Information
7.10.2 GEODIS Business Overview
7.10.3 GEODIS Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.10.4 GEODIS Biopharmaceutical Logistic Product Portfolio
7.10.5 GEODIS Recent Developments
7.11 VersaCold
7.11.1 VersaCold Comapny Information
7.11.2 VersaCold Business Overview
7.11.3 VersaCold Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.11.4 VersaCold Biopharmaceutical Logistic Product Portfolio
7.11.5 VersaCold Recent Developments
7.12 Agility
7.12.1 Agility Comapny Information
7.12.2 Agility Business Overview
7.12.3 Agility Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.12.4 Agility Biopharmaceutical Logistic Product Portfolio
7.12.5 Agility Recent Developments
7.13 DSV
7.13.1 DSV Comapny Information
7.13.2 DSV Business Overview
7.13.3 DSV Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.13.4 DSV Biopharmaceutical Logistic Product Portfolio
7.13.5 DSV Recent Developments
7.14 Sinotrans
7.14.1 Sinotrans Comapny Information
7.14.2 Sinotrans Business Overview
7.14.3 Sinotrans Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.14.4 Sinotrans Biopharmaceutical Logistic Product Portfolio
7.14.5 Sinotrans Recent Developments
7.15 Kerry Logistics
7.15.1 Kerry Logistics Comapny Information
7.15.2 Kerry Logistics Business Overview
7.15.3 Kerry Logistics Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.15.4 Kerry Logistics Biopharmaceutical Logistic Product Portfolio
7.15.5 Kerry Logistics Recent Developments
7.16 SF Express
7.16.1 SF Express Comapny Information
7.16.2 SF Express Business Overview
7.16.3 SF Express Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.16.4 SF Express Biopharmaceutical Logistic Product Portfolio
7.16.5 SF Express Recent Developments
7.17 CEVA
7.17.1 CEVA Comapny Information
7.17.2 CEVA Business Overview
7.17.3 CEVA Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.17.4 CEVA Biopharmaceutical Logistic Product Portfolio
7.17.5 CEVA Recent Developments
7.18 CH Robinson
7.18.1 CH Robinson Comapny Information
7.18.2 CH Robinson Business Overview
7.18.3 CH Robinson Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.18.4 CH Robinson Biopharmaceutical Logistic Product Portfolio
7.18.5 CH Robinson Recent Developments
7.19 Air Canada Cargo
7.19.1 Air Canada Cargo Comapny Information
7.19.2 Air Canada Cargo Business Overview
7.19.3 Air Canada Cargo Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
7.19.4 Air Canada Cargo Biopharmaceutical Logistic Product Portfolio
7.19.5 Air Canada Cargo Recent Developments
8 North America
8.1 North America Biopharmaceutical Logistic Revenue (2019-2030)
8.2 North America Biopharmaceutical Logistic Revenue by Type (2019-2030)
8.2.1 North America Biopharmaceutical Logistic Revenue by Type (2019-2024)
8.2.2 North America Biopharmaceutical Logistic Revenue by Type (2025-2030)
8.3 North America Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
8.4 North America Biopharmaceutical Logistic Revenue by Application (2019-2030)
8.4.1 North America Biopharmaceutical Logistic Revenue by Application (2019-2024)
8.4.2 North America Biopharmaceutical Logistic Revenue by Application (2025-2030)
8.5 North America Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
8.6 North America Biopharmaceutical Logistic Revenue by Country
8.6.1 North America Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Biopharmaceutical Logistic Revenue by Country (2019-2024)
8.6.3 North America Biopharmaceutical Logistic Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Biopharmaceutical Logistic Revenue (2019-2030)
9.2 Europe Biopharmaceutical Logistic Revenue by Type (2019-2030)
9.2.1 Europe Biopharmaceutical Logistic Revenue by Type (2019-2024)
9.2.2 Europe Biopharmaceutical Logistic Revenue by Type (2025-2030)
9.3 Europe Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
9.4 Europe Biopharmaceutical Logistic Revenue by Application (2019-2030)
9.4.1 Europe Biopharmaceutical Logistic Revenue by Application (2019-2024)
9.4.2 Europe Biopharmaceutical Logistic Revenue by Application (2025-2030)
9.5 Europe Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
9.6 Europe Biopharmaceutical Logistic Revenue by Country
9.6.1 Europe Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Biopharmaceutical Logistic Revenue by Country (2019-2024)
9.6.3 Europe Biopharmaceutical Logistic Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Biopharmaceutical Logistic Revenue (2019-2030)
10.2 China Biopharmaceutical Logistic Revenue by Type (2019-2030)
10.2.1 China Biopharmaceutical Logistic Revenue by Type (2019-2024)
10.2.2 China Biopharmaceutical Logistic Revenue by Type (2025-2030)
10.3 China Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
10.4 China Biopharmaceutical Logistic Revenue by Application (2019-2030)
10.4.1 China Biopharmaceutical Logistic Revenue by Application (2019-2024)
10.4.2 China Biopharmaceutical Logistic Revenue by Application (2025-2030)
10.5 China Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Biopharmaceutical Logistic Revenue (2019-2030)
11.2 Asia Biopharmaceutical Logistic Revenue by Type (2019-2030)
11.2.1 Asia Biopharmaceutical Logistic Revenue by Type (2019-2024)
11.2.2 Asia Biopharmaceutical Logistic Revenue by Type (2025-2030)
11.3 Asia Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
11.4 Asia Biopharmaceutical Logistic Revenue by Application (2019-2030)
11.4.1 Asia Biopharmaceutical Logistic Revenue by Application (2019-2024)
11.4.2 Asia Biopharmaceutical Logistic Revenue by Application (2025-2030)
11.5 Asia Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
11.6 Asia Biopharmaceutical Logistic Revenue by Country
11.6.1 Asia Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Biopharmaceutical Logistic Revenue by Country (2019-2024)
11.6.3 Asia Biopharmaceutical Logistic Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Biopharmaceutical Logistic Revenue (2019-2030)
12.2 MEALA Biopharmaceutical Logistic Revenue by Type (2019-2030)
12.2.1 MEALA Biopharmaceutical Logistic Revenue by Type (2019-2024)
12.2.2 MEALA Biopharmaceutical Logistic Revenue by Type (2025-2030)
12.3 MEALA Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
12.4 MEALA Biopharmaceutical Logistic Revenue by Application (2019-2030)
12.4.1 MEALA Biopharmaceutical Logistic Revenue by Application (2019-2024)
12.4.2 MEALA Biopharmaceutical Logistic Revenue by Application (2025-2030)
12.5 MEALA Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
12.6 MEALA Biopharmaceutical Logistic Revenue by Country
12.6.1 MEALA Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Biopharmaceutical Logistic Revenue by Country (2019-2024)
12.6.3 MEALA Biopharmaceutical Logistic Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings